- Home
- TIRX vs GNLX Comparison
TIRX vs GNLX Comparison
Compare TIRX & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- GNLX
- Stock Information
- Founded
- TIRX 2010
- GNLX 2001
- Country
- TIRX China
- GNLX United States
- Employees
- TIRX N/A
- GNLX N/A
- Industry
- TIRX Specialty Insurers
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- TIRX Finance
- GNLX Health Care
- Exchange
- TIRX Nasdaq
- GNLX Nasdaq
- Market Cap
- TIRX 118.4M
- GNLX 128.0M
- IPO Year
- TIRX 2021
- GNLX 2023
- Fundamental
- Price
- TIRX $0.88
- GNLX $3.15
- Analyst Decision
- TIRX
- GNLX Strong Buy
- Analyst Count
- TIRX 0
- GNLX 5
- Target Price
- TIRX N/A
- GNLX $16.20
- AVG Volume (30 Days)
- TIRX 43.9K
- GNLX 136.2K
- Earning Date
- TIRX 08-15-2025
- GNLX 08-07-2025
- Dividend Yield
- TIRX N/A
- GNLX N/A
- EPS Growth
- TIRX N/A
- GNLX N/A
- EPS
- TIRX N/A
- GNLX N/A
- Revenue
- TIRX N/A
- GNLX N/A
- Revenue This Year
- TIRX N/A
- GNLX N/A
- Revenue Next Year
- TIRX N/A
- GNLX N/A
- P/E Ratio
- TIRX N/A
- GNLX N/A
- Revenue Growth
- TIRX 158.74
- GNLX N/A
- 52 Week Low
- TIRX $0.89
- GNLX $1.91
- 52 Week High
- TIRX $2.65
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- TIRX 20.53
- GNLX 44.93
- Support Level
- TIRX $0.90
- GNLX $3.32
- Resistance Level
- TIRX $1.03
- GNLX $3.61
- Average True Range (ATR)
- TIRX 0.04
- GNLX 0.24
- MACD
- TIRX -0.01
- GNLX -0.04
- Stochastic Oscillator
- TIRX 0.00
- GNLX 1.79
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.